Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the battle

Dr. Ann Payne-Johnson from USA Family Medicine in partnership with Accordia Health joined WKRG News 5 on The Doctor Is In to share her insight on alternatives to weight loss injections. Dr. Payne-John

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to be effective for weight loss. It has been recommended as a weight loss drug for adults, with proposals for the phased launch of it on the NHS being set out by NICE.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.

A nurse’s death has been linked to a weight loss drug which is approved for use on the NHS. Susan McGowan, 58, died on September 4 and had recently taken two doses of the weight loss jab Mounjaro. The drug,

The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,

Susan McGowan, 58, (pictured) from Lanarkshire, died after taking two low-dose injections of tirzepatide, known under the brand name Mounjaro.